| Company | Date | Position | Consensus β | Price Target β | 2-Yr Return | vs S&P 500 β |
|---|---|---|---|---|---|---|
|
CERT
Certara
|
Oct 07, 2026 | HOLD |
Buy
+44.5% avg upside
23 analysts
|
$9.00
1.50% Downside
|
+3.2% | Β· |
|
GH
Guardant Health
|
Oct 07, 2026 | BUY |
Strong Buy
+2.9% avg upside
32 analysts
|
$220.00
31.31% Upside
|
-0.5% | Β· |
|
TWST
Twist Bioscience
|
Oct 07, 2026 | BUY |
Strong Buy
-29.2% avg upside
16 analysts
|
$215.00
34.66% Upside
|
+2.6% | Β· |
|
AVTR
Avantor
|
Oct 07, 2026 | SELL |
Buy
+1.8% avg upside
26 analysts
|
$15.00
4.21% Downside
|
-0.3% | Β· |
|
TXG
10x Genomics
|
Oct 07, 2026 | BUY |
Buy
-25.7% avg upside
19 analysts
|
$110.00
36.46% Upside
|
Β· | Β· |
|
SHC
Sotera Health
|
Oct 07, 2026 | BUY |
Strong Buy
+21.7% avg upside
13 analysts
|
$22.00
21.83% Upside
|
+1.3% | Β· |
|
A
Agilent
|
Oct 07, 2026 | BUY |
Strong Buy
-6.4% avg upside
34 analysts
|
$195.00
14.28% Upside
|
+0.9% | Β· |
|
BRKR
Bruker
|
Oct 07, 2026 | BUY |
Buy
+2.0% avg upside
22 analysts
|
$70.00
18.94% Upside
|
-1.9% | Β· |
|
DHR
Danaher
|
Oct 07, 2026 | BUY |
Strong Buy
-1.1% avg upside
47 analysts
|
$255.00
16.05% Upside
|
-0.5% | Β· |
|
ICLR
Icon
|
Oct 07, 2026 | HOLD |
Strong Buy
+14.1% avg upside
27 analysts
|
$175.00
6.58% Upside
|
+1.1% | Β· |
|
ILMN
Illumina
|
Oct 07, 2026 | SELL |
Buy
-28.5% avg upside
31 analysts
|
$200.00
28.11% Downside
|
-1.3% | Β· |
|
LH
Labcorp Holdings
|
Oct 07, 2026 | HOLD |
Strong Buy
-14.4% avg upside
37 analysts
|
$330.00
5.73% Upside
|
+0.0% | Β· |
|
MTD
Mettler-Toledo
|
Oct 07, 2026 | BUY |
Buy
-18.9% avg upside
19 analysts
|
$1700.00
9.73% Upside
|
-0.3% | Β· |
|
PACB
Pacific Biosciences
|
Oct 07, 2026 | SELL |
Buy
+95.1% avg upside
14 analysts
|
$1.25
46.31% Downside
|
+15.4% | Β· |
|
RVTY
Revvity
|
Oct 07, 2026 | HOLD |
Buy
-21.5% avg upside
24 analysts
|
$160.00
3.71% Upside
|
+0.0% | Β· |
|
DGX
Quest Diagnostics
|
Oct 07, 2026 | BUY |
Buy
-20.0% avg upside
34 analysts
|
$260.00
12.63% Upside
|
+1.7% | Β· |
|
RGEN
Repligen
|
Oct 07, 2026 | BUY |
Strong Buy
+2.2% avg upside
25 analysts
|
$225.00
29.46% Upside
|
Β· | Β· |
|
TMO
Thermo Fisher
|
Oct 07, 2026 | BUY |
Strong Buy
-5.4% avg upside
40 analysts
|
$750.00
14.01% Upside
|
-2.1% | Β· |
|
WAT
Waters
|
Oct 07, 2026 | BUY |
Strong Buy
-6.5% avg upside
31 analysts
|
$500.00
15.28% Upside
|
-2.4% | Β· |
|
WST
West Pharmaceutical Services
|
Oct 07, 2026 | BUY |
Strong Buy
+1.3% avg upside
18 analysts
|
$440.00
20.27% Upside
|
-0.9% | Β· |
|
IQV
IQVIA Holdings
|
Oct 07, 2026 | BUY |
Strong Buy
-2.2% avg upside
40 analysts
|
$300.00
15.39% Upside
|
-2.0% | Β· |
|
NTRA
Natera
|
Oct 07, 2026 | BUY |
Strong Buy
-16.1% avg upside
28 analysts
|
$475.00
18.57% Upside
|
+1.3% | Β· |
|
MEDP
Medpace Holdings
|
Oct 07, 2026 | HOLD |
Hold
-17.0% avg upside
18 analysts
|
$625.00
2.12% Upside
|
+1.3% | Β· |
|
QGEN
Qiagen
|
Oct 06, 2026 | BUY |
Buy
-4.0% avg upside
24 analysts
|
$55.00
21.19% Upside
|
+0.0% | Β· |
|
FTRE
Fortrea Holdings Inc.
|
Oct 06, 2026 | BUY |
Buy
-1.6% avg upside
13 analysts
|
$23.00
10.36% Upside
|
-1.1% | Β· |
|
CRL
Charles River Labs
|
Sep 24, 2026 | BUY |
Strong Buy
-15.0% avg upside
36 analysts
|
$330.00
9.35% Upside
|
-0.5% | Β· |
|
LUMN
Lumen Technologies
|
Jun 12, 2023 | HOLD |
Hold
+102.5% avg upside
21 analysts
|
$42.00
695.44% Upside
|
+129.5% | Β· |
|
JBHT
JB Hunt
|
Jan 18, 2023 | BUY |
Strong Buy
+13.3% avg upside
33 analysts
|
$200.00
12.77% Downside
|
-5.1% | Β· |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.